Literature DB >> 23873730

Peptide matching between Epstein-Barr virus and human proteins.

Giovanni Capone1, Michele Calabrò, Guglielmo Lucchese, Candida Fasano, Bruna Girardi, Lorenzo Polimeno, Darja Kanduc.   

Abstract

Epstein-Barr virus proteins were examined for amino acid sequence matching to human proteins at the decapeptide level. We report that numerous EBV peptides of different length (from 10- to 13-mer) are present in 28 human proteins. The viral vs. human peptide overlap mainly involves the glycine-rich region allocated in the NH2 terminus of Epstein-Barr nuclear antigen 1 protein and host cellular components that play crucial roles in basic biochemical pathways, such as chromatin remodeling, RNA splicing, transmission across chemical/electrical synapses, and neurogenesis, and that, when altered, may characterize various pathologies such as immunodeficiency, systemic lupus erythematosus, myelination, and speech disorders. The present results might contribute to understand and define the (physio) pathological relationships and interactions occurring between EBV and the human host.
© 2013 Federation of European Microbiological Societies. Published by John Wiley & Sons Ltd. All rights reserved.

Entities:  

Keywords:  EBV EBNA1; EBV immunoevasion; EBV proteins; glycine-rich region; human proteins; peptide matching

Mesh:

Substances:

Year:  2013        PMID: 23873730     DOI: 10.1111/2049-632X.12066

Source DB:  PubMed          Journal:  Pathog Dis        ISSN: 2049-632X            Impact factor:   3.166


  7 in total

1.  HPV and systemic lupus erythematosus: a mosaic of potential crossreactions.

Authors:  Yahel Segal; Shani Dahan; Michele Calabrò; Darja Kanduc; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2017-04       Impact factor: 2.829

2.  Cumulative Roles for Epstein-Barr Virus, Human Endogenous Retroviruses, and Human Herpes Virus-6 in Driving an Inflammatory Cascade Underlying MS Pathogenesis.

Authors:  Ute-Christiane Meier; Richard Christopher Cipian; Abbas Karimi; Ranjan Ramasamy; Jaap Michiel Middeldorp
Journal:  Front Immunol       Date:  2021-11-01       Impact factor: 7.561

Review 3.  Epstein-Barr virus and multiple sclerosis.

Authors:  Samantha S Soldan; Paul M Lieberman
Journal:  Nat Rev Microbiol       Date:  2022-08-05       Impact factor: 78.297

4.  The Role of Codon Usage, tRNA Availability, and Cell Proliferation in EBV Latency and (Re)Activation.

Authors:  Darja Kanduc
Journal:  Glob Med Genet       Date:  2022-09-15

5.  EBV-Associated Cancer and Autoimmunity: Searching for Therapies.

Authors:  Giovanni Capone; Candida Fasano; Guglielmo Lucchese; Michele Calabrò; Darja Kanduc
Journal:  Vaccines (Basel)       Date:  2015-02-05

6.  From Anti-EBV Immune Responses to the EBV Diseasome via Cross-reactivity.

Authors:  Darja Kanduc; Yehuda Shoenfeld
Journal:  Glob Med Genet       Date:  2020-08-31

7.  Serological Evidence for the Association Between Epstein-Barr Virus Infection and Sjögren's Syndrome.

Authors:  Jingxiu Xuan; Zhiqian Ji; Bin Wang; Xiaoli Zeng; Rongjuan Chen; Yan He; Peishi Rao; Puqi Wu; Guixiu Shi
Journal:  Front Immunol       Date:  2020-10-30       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.